These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26047596)

  • 1. Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.
    Gul CB; Yildiz A; Ersoy A; Kahvecioglu S; Asiltas B; Yildirim F; Ermurat S; Sag S; Oruc A; Gullulu S; Gullulu M
    Int Urol Nephrol; 2015 Jul; 47(7):1187-94. PubMed ID: 26047596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial dysfunction in early autosomal dominant polycystic kidney disease independent of fibroblast growth factor 23.
    Yildiz A; Gul CB; Ersoy A; Asiltas B; Ermurat S; Dogan S; Karaagac K; Sag S; Oruc A; Aktas N; Ocakoglu G; Dogan I; Gullulu S; Gullulu M
    Iran J Kidney Dis; 2014 Nov; 8(6):443-9. PubMed ID: 25362218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; Wang W; Farmer-Bailey H; Gitomer B; Malaczewski M; Klawitter J; Jovanovich A; Chonchol M
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1493-1501. PubMed ID: 30228110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.
    Orscelik O; Kocyigit I; Akpek M; Dogdu O; Kaya C; Unal A; Sipahioglu M; Tokgoz B; Zengin H; Oymak O; Kaya MG
    J Investig Med; 2013 Mar; 61(3):597-603. PubMed ID: 23360844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Coban M; Inci A; Yılmaz U; Asilturk E
    Kidney Blood Press Res; 2018; 43(4):1160-1173. PubMed ID: 30064143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease.
    Sági B; Késői I; Késői B; Vas T; Csiky B; Kovács T; Nagy J
    Physiol Int; 2018 Jun; 105(2):145-156. PubMed ID: 29975128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study.
    Parlak A; Aydoğan U; Iyisoy A; Dikililer MA; Kut A; Cakır E; Sağlam K
    Anadolu Kardiyol Derg; 2012 Jun; 12(4):298-304. PubMed ID: 22466361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of inflammatory biomarkers in coronary artery disease: PTX3 as a new inflammatory marker.
    Guo T; Huang L; Liu C; Shan S; Li Q; Ke L; Cheng B
    Exp Gerontol; 2017 Oct; 97():64-67. PubMed ID: 28778748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.
    Nowak KL; Farmer H; Cadnapaphornchai MA; Gitomer B; Chonchol M
    Nephrol Dial Transplant; 2017 Feb; 32(2):342-347. PubMed ID: 28186577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.
    Weitoft T; Larsson A; Saxne T; Manivel VA; Lysholm J; Knight A; Rönnelid J
    Scand J Rheumatol; 2017 Sep; 46(5):346-352. PubMed ID: 27973973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis.
    Sharma A; Khan R; Gupta N; Sharma A; Zaheer MS; Abbas M; Khan SA
    Clin Chim Acta; 2018 May; 480():65-70. PubMed ID: 29408170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease.
    Kocyigit I; Eroglu E; Orscelik O; Unal A; Gungor O; Ozturk F; Karakukcu C; Imamoglu H; Sipahioglu MH; Tokgoz B; Oymak O
    J Nephrol; 2014 Apr; 27(2):181-6. PubMed ID: 24515315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of QTc interval and global autonomic activity in autosomal dominant polycystic kidney disease and atherosclerotic renal artery stenosis hypertensive patients.
    Lai S; Perrotta AM; Bagordo D; Mazzaferro S; Menè P; Gigante A; Tinti F; Galani A; Cianci R
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6333-6338. PubMed ID: 34730214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis.
    Yigit IP; Dogukan A; Taskapan H; Comert M; Ilhan N; Ulu R; Aygen B
    J Vasc Access; 2015; 16(5):377-81. PubMed ID: 26070095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
    Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
    Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.
    Heffernan KS; Kuvin JT; Sarnak MJ; Perrone RD; Miskulin DC; Rudym D; Chandra P; Karas RH; Menon V
    Nephrol Dial Transplant; 2011 Aug; 26(8):2515-21. PubMed ID: 21292815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients.
    Kocyigit I; Kaya MG; Orscelik O; Kaya C; Akpek M; Zengin H; Sipahioglu MH; Unal A; Yilmaz MI; Tokgoz B; Oymak O; Axelsson J
    Am J Nephrol; 2012; 36(1):11-8. PubMed ID: 22699414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibulin Levels in Autosomal Dominant Polycystic Kidney Disease and Its Relationship to Arterial Stiffness.
    Inci A; Akin O; Ellidag HY; Eren E; Dolu S; Sari F
    Clin Lab; 2017 Nov; 63(11):1869-1874. PubMed ID: 29226648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease.
    Pradeep AR; Kathariya R; Raghavendra NM; Sharma A
    J Periodontol; 2011 May; 82(5):734-41. PubMed ID: 21080790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individuals.
    Miyaki A; Maeda S; Choi Y; Akazawa N; Eto M; Tanaka K; Ajisaka R
    Am J Hypertens; 2013 Oct; 26(10):1250-5. PubMed ID: 23771016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.